← All organizations
Highest phase reached
Phase 2
First clinical trial
Jun 1, 2010Last known activity
Jun 1, 2017
Acquired by Biontech on May 8, 2019
Timeline
Drugs by trial phase (15 distinct, 25 trials)
Phase 3 (0 own, 5 via acquisition)
Phase 2 (2 own, 4 via acquisition)
Phase 1 (3 own, 1 via acquisition)
Indications
Studied for
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (5)
- NCT03118349Lead sponsorPhase 1Jun 1, 2017
- NCT02687230Lead sponsorPhase 1Jul 1, 2016
- NCT02687230Study directorPhase 1Jul 1, 2016
- NCT02672917Lead sponsorPhase 1Jan 1, 2016
- NCT01141491Lead sponsorPhase 2Jun 1, 2010
Details
- Founded
- San Diego, CA, US Jun 1, 2006
- Last known activity
- Jun 1, 2017